Quantifying disease progression in amyotrophic lateral sclerosis.
about
INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS modelRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisDeep learning predictions of survival based on MRI in amyotrophic lateral sclerosis.Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise.Diffusion weighted MRI and tractography for evaluating peripheral nerve degeneration and regenerationAn improved electrical impedance myography (EIM) tongue array for use in clinical trials.Does the MUNIX Method Reflect Clinical Dysfunction in Amyotrophic Lateral Sclerosis: A Practical Experience.Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review.Motor neuron disease: current management and future prospects.New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Further development of biomarkers in amyotrophic lateral sclerosis.Fixed dynamometry is more sensitive than vital capacity or ALS rating scale.Neuropsychological assessment in different King's clinical stages of amyotrophic lateral sclerosis.Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression.UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort.Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.Imaging muscle as a potential biomarker of denervation in motor neuron disease.Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis.Chronic electromyograms in treadmill running SOD1 mice reveal early changes in muscle activation.Measuring change in amyotrophic lateral sclerosis.Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS.Peripheral nerve diffusion tensor imaging is reliable and reproducible.Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis
P2860
Q27321452-DE492283-AB01-47F7-AFA2-A45D562DFB1CQ27338320-E73B4F7F-1976-49A0-9F2D-08B2C973A8F8Q30365956-1DA24947-242F-46B5-98E8-92D39C025981Q33774120-B6ECF259-26ED-43A3-8D30-B7F48181FDFCQ35046924-600744B9-4833-477A-9343-E3843EC567E8Q36421991-B8889191-2E48-4240-967C-7B2DE0A47F69Q36993547-26BF9271-C1B8-49EC-9F74-72BE06AFAEE2Q38336261-5C883028-5E6F-4E26-89DC-C48BD398E91FQ38597450-BC6C36F3-728D-4961-A2FB-9AF63F9D21E8Q38701109-B6D312EE-CC76-4632-8A0F-C58234C792E9Q38847200-CA1E1811-4817-43E7-A5A4-29D5F314430AQ38856405-02750191-E7DB-43D8-940D-990B1543A0AEQ39000702-0A623001-66CD-4AEF-A6F0-7188B65C5097Q39976121-5A9BA076-F771-4192-B28A-7320AA3C2706Q40385384-A6020F8F-2063-48E7-B78F-F4945834B247Q41596665-1D4C17A2-9139-4948-9767-CBCF68DFEBCDQ47593807-5F2FA1F6-90F7-4E9D-AD4D-D0C8CD3952B8Q47624980-44727ECF-4D32-4809-B659-6E5428578120Q48005648-2D4BF39F-2493-4D35-A2C4-D96BE1B72EC1Q48099230-7781860B-E01F-45AF-B0C7-1A8DEBEBC9F2Q48165273-F59D8816-8605-4D37-B35E-3D5474B8A3FAQ48278519-3C7ADD07-FD72-408A-BE32-34028C70C456Q50980538-5339472F-7AD6-43E2-8AE6-83EEE529D55DQ50993029-D6492236-3FCF-4290-B6C0-3B725973EF16Q51733178-73D426A7-1478-43CF-8F47-A4429B648599Q56525449-73012892-7006-4250-94C4-AD7188899575
P2860
Quantifying disease progression in amyotrophic lateral sclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantifying disease progression in amyotrophic lateral sclerosis.
@ast
Quantifying disease progression in amyotrophic lateral sclerosis.
@en
type
label
Quantifying disease progression in amyotrophic lateral sclerosis.
@ast
Quantifying disease progression in amyotrophic lateral sclerosis.
@en
prefLabel
Quantifying disease progression in amyotrophic lateral sclerosis.
@ast
Quantifying disease progression in amyotrophic lateral sclerosis.
@en
P2860
P50
P356
P1433
P1476
Quantifying disease progression in amyotrophic lateral sclerosis.
@en
P2093
Jeremy Shefner
Neil G Simon
P2860
P304
P356
10.1002/ANA.24273
P5008
P577
2014-09-30T00:00:00Z
2014-11-01T00:00:00Z